
Retatrutide 30mg
£87.99
Triple agonist (GLP-1/GIP/Glucagon) — 30mg research compound. Lab-verified, 99%+ purity.
In-Depth Research Guide
Mechanism of action, studies & citations
For professional laboratory research only.
- • Not a medicine.
- • Not sterile unless independently validated as sterile.
- • Not for administration to humans or animals.
- • Not for diagnostic or therapeutic use.
Live — What Others Are Viewing
Updates liveRelated Research Guides
In-depth research articles covering this compound and its laboratory applications.
Understanding Retatrutide 30mg
A quick research-focused overview of this compound and what it's studied for.
What is it good for?
Triple-receptor (GLP-1/GIP/Glucagon) metabolic research models in in-vitro and preclinical research.
What does it do?
A triple agonist targeting GLP-1, GIP, and glucagon receptors — the broadest metabolic research footprint of the GLP-1 class.
Observed in research
In research models, the glucagon arm is associated with lipolysis and energy-expenditure signalling alongside the increin effects.
For laboratory research use only. The effects described refer to observations in research models, not human use.
Customer Reviews
Log in to leave a review. Only verified customers can review our products.


















